MARINUS PHARMACEUTICALS PRESENTS CLINICAL DATA FROM PIVOTAL PHASE 3 RAISE TRIAL IN REFRACTORY STATUS EPILEPTICUS AT THE NEUROCRITICAL CARE SOCIETY 2024 ANNUAL MEETING

Reuters · 10/17 11:00

Please log in to view news